Date  Sort Arrow Headline
Feb 7, 2019 Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
Feb 22, 2019 Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer
Feb 25, 2019 Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference
Feb 26, 2019 Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates
Mar 1, 2019 Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019
Mar 6, 2019 Innovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in Boston
Mar 13, 2019 Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019
Mar 18, 2019 Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial
Mar 18, 2019 Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019
Mar 19, 2019 Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights